New cancer drug tested for safety in advanced cases
NCT ID NCT02711137
Summary
This early-phase study aimed to find a safe dose and check the side effects of a new drug called INCB057643 for people with advanced cancers that had stopped responding to other treatments. It tested the drug alone and combined with standard treatments in about 137 participants with various solid tumors and blood cancers. The main goal was to understand how much of the drug the body could tolerate and its initial safety profile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hematology - Oncology Associates of Treasure Coast
Port Saint Lucie, Florida, 34952, United States
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
HÔPITAL SAINT-LOUIS, Service Hématologie Adultes
Paris, 75010, France
-
Institut Jules Bordet, Clinical Trial Conduct Unit
Brussels, B-1000, Belgium
-
MultiCare Institute for Research and Innovation
Tacoma, Washington, 98405, United States
-
Oncology Consultants, P.A.
Houston, Texas, 77030, United States
-
Sarah Cannon Research Institute at Health One
Denver, Colorado, 80218, United States
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
The Methodist Hospital
Houston, Texas, 77030, United States
-
University of Alabama
Birmingham, Alabama, 35294-3300, United States
-
University of California
La Jolla, California, 92093, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Rochester, Wilmot Cancer Center
Rochester, New York, 14642, United States
-
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Yale University
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.